Summary of - PowerPoint PPT Presentation

About This Presentation
Title:

Summary of

Description:

This increases the amount of time substances stay in the intestine, allowing for ... Abuse of the drug or other substances may lead to severe psychological or ... – PowerPoint PPT presentation

Number of Views:68
Avg rating:3.0/5.0
Slides: 40
Provided by: johnb54
Learn more at: https://s2.smu.edu
Category:

less

Transcript and Presenter's Notes

Title: Summary of


1
Summary of Structure-Activity Relationships
(SARs)
2
What structural elements are necessary for
activity?
3
Removing the oxide bridge (and hydrogenating
double bond, removing one alcohol) produces
levorphanol, which has enhanced analgesic
properties over morphine.
Levorphanol is used to treat severe pain and has
several brand names.
4
Generic Name Levorphanol Brand Names/Synonyms Ant
algin Aromarone Cetarin Dea No. 9220 Dea No.
9733 Dromoran Lemoran Levo-Dromoran Levorfanol
Inn-Spanish Levorfanolo Dcit Levorphan Levorph
anal Levorphanol Dl-Form Levorphanol
Tartrate Levorphanolum Inn-Latin Methorfinan
Czech Methorphinan Orphan Racemethorphanum Racem
ic Dromoran Racemorfano Inn-Spanish Racemorphan
Racemorphan BanInn Racemorphane
Inn-French Racemorphanum Inn-Latinanum
Inn-Latin
5
Surprisingly, its mirror image still has
antitussive properties, but no analgesic
properties
6
Methylating the phenolic hydroxyl group improves
this antitussive activity(and increase oral
bioavailability)
7
Dextromethorphan (DM or DXM) is an antitussive
drug that is found in many over-the-counter cold
and cough preparations, usually in the form of
dextromethorphan hydrobromide. It is also
commonly taken above the recommended dosage by
users seeking its dissociative effect.
8
(No Transcript)
9
(No Transcript)
10
Meperidine
  • Pethidine (INN) or meperidine (USAN) (also
    referred to as Demerol) is a fast-acting opioid
    analgesic drug.
  • In the United States, it is more commonly known
    as meperidine or by its brand name Demerol.
  • Pethidine is indicated for the treatment of
    moderate to severe pain, and is delivered as its
    hydrochloride salt in tablets (oral), as a syrup,
    or by intramuscular or intravenous injection.

11
Meperidine (Pethidine, Demerol)
  • For much of the 20th century, pethidine was the
    opioid of choice for many physicians in 1983 60
    of doctors prescribed it for acute pain and 22
    for chronic severe pain.
  • Compared to morphine, pethidine was supposed to
    be safer and carry less risk of addiction, and to
    be superior in treating the pain associated with
    biliary spasm or renal colic due to its putative
    antispasmodic effects.
  • It has fallen out of favor in recent years.

12
Opioids to treat diarrhea?
13
Diphenoxylate
  • Diphenoxylate is an opioid agonist used for the
    treatment of diarrhea that acts by slowing
    intestinal contractions.
  • It was discovered at Janssen Pharmaceutica in
    1956.

14
Diphenoxylate
  • It is a congener to the narcotic Meperidine of
    which the common brand name is Demerol.
  • This being the case, this medication is
    potentially habit-forming, particularly in high
    doses or when long-time usage is involved.

15
Lomotil(Diphenoxylate Atropine)
  • To avoid potential abuse, diphenoxylate is
    manufactured and marketed as a combination drug
    with atropine (Lomotil).
  • Atropine is a competitive antagonist of the
    muscarinic acetylcholine receptors
  • Due to the presence of atropine, ingestion of too
    much Lomotil thus causes nausea and muscle
    weakness.

16
Lomotil(Diphenoxylate Atropine)
17
Loperamide (Imodium)
  • Loperamide is an opioid receptor agonist and acts
    on the µ-opioid receptors in the myenteric plexus
    large intestines
  • it does not affect the central nervous system
    like other opioids.

18
myenteric plexus
19
Loperamide (Imodium)
  • Loperamide works by decreasing the activity of
    the myenteric plexus which decreases the motility
    of the circular and longitudinal smooth muscles
    of the intestinal wall.
  • This increases the amount of time substances stay
    in the intestine, allowing for more water to be
    absorbed out of the fecal matter.
  • Loperamide also decreases colonic mass movements
    and suppresses the gastrocolic reflex

20
Loperamide (Imodium)
  • Loperamide does not cross the blood-brain barrier
    and has no analgesic properties. Tolerance in
    response to long-term use has not been
    reported.However, loperamide can cause physical
    dependence. Symptoms of opiate withdrawal have
    been observed in patients abruptly discontinuing
    long-term therapy with loperamide.

21
Fentanyl
22
Fentanyl
  • Fentanyl is an opioid analgesic, first
    synthesized by Janssen Pharmaceutica (Belgium) in
    the late 1950s, with an analgesic potency of
    about 80 times that of morphine.
  • Fentanyl was introduced into medical practice in
    the 1960s as an intravenous anesthetic under the
    trade name of Sublimaze.

23
(No Transcript)
24
(No Transcript)
25
Fentanyl analogs
26
Fentanyl and analogs
  • Fentanyls are extensively used for anesthesia and
    analgesia, most often in the operating room and
    intensive care unit.
  • Duragesic, by Janssen Pharmaceutica, is a
    fentanyl transdermal patch used in chronic pain
    management.
  • Duragesic patches work by releasing fentanyl into
    body fats, which then slowly release the drug
    into the blood stream over 72 hours, allowing for
    long lasting relief from pain.

27
Carfentanil
  • Carfentanil was discovered by Janssen
    Pharmaceutica.
  • It has a quantitative potency approximately
    10,000 times that of morphine and 100 times that
    of fentanyl, activity in humans starting at about
    1 µg.

28
Carfentanil
  • Carfentanil is marketed under the trade name
    Wildnil as a tranquilizer for large animals. It
    is intended for animal use only as its extreme
    potency makes it inappropriate for use in humans.

29
Carfentanil
  • It is thought that in the 2002 Moscow theater
    hostage crisis, the Russian military made use of
    an aerosol form of carfentanil to subdue Chechen
    hostage takers.
  • Its short action, easy reversibility and
    therapeutic index (10600 vs. 300 for fentanyl)
    would make it a near-perfect agent for this
    purpose.

30
Carfentanil
  • Wax et al. surmise from the available evidence
    that the Moscow emergency services had not been
    informed of the use of the agent, and therefore
    did not have adequate supplies of naloxone or
    naltrexone (opioid antagonists) to prevent
    complications in many of the victims.
  • Assuming that carfentanil was the only active
    constituent (which has not been verified by the
    Russian military), the primary acute toxic effect
    to the theatre victims would have been
    opioid-induced apnea in this case mechanical
    ventilation and/or treatment with opioid
    antagonists would have been life-saving for many
    or all victims.

31
Methadone
32
Methadone
  • Methadone/dolophine, was first synthesized in
    1937 by German scientists Max Bockmuhl and Gustav
    Ehrhart at IG Farben (Hoechst-Am-Main, now part
    of Frankfurt, Germany) during their search for an
    analgesic that would be easier to use during
    surgery (and less potentially addictive, post-op)
    than morphine.

33
Methadone
  • Methadone was introduced into the United States
    in 1947 by Eli Lilly and Company as an analgesic
    (They gave it the trade name Dolophine, which is
    now registered to Roxane Laboratories).
  • Since then, it has been best known for its use in
    treating narcotic addiction, although such a use
    never became widespread and common until the
    early 1990's when public policy sought to find
    ways to reduce the spread of HIV and AIDS.

34
Scheduling of Drugs
  • The Controlled Substances Act was introduced into
    law in 1970
  • According to the CSA, drugs are classified or
    scheduled depending on their potential for
    abuse and whether or not there is a medical need
    for a particular drug.

35
Schedule I drugs
  • Findings required
  • (A) The drug or other substance has a high
    potential for abuse.
  • (B) The drug or other substance has no currently
    accepted medical use in treatment in the United
    States.
  • (C) There is a lack of accepted safety for use of
    the drug or other substance under medical
    supervision.
  • Examples include Heroin, Cannabis, and LSD

36
Schedule II drugs
  • Findings required
  • The drug or other substance has a high potential
    for abuse.
  • The drug or other substance has a currently
    accepted medical use in treatment in the United
    States or a currently accepted medical use with
    severe restrictions.
  • Abuse of the drug or other substances may lead
    to severe psychological or physical dependence.
  • Examples include Morphine, Cocaine,
    Methylphenidate (Ritalin)

37
Schedule III drugs
  • Findings required
  • (A) The drug or other substance has a potential
    for abuse less than the drugs or other substances
    in schedules I and II.
  • (B) The drug or other substance has a currently
    accepted medical use in treatment in the United
    States.
  • (C) Abuse of the drug or other substance may lead
    to moderate or low physical dependence or high
    psychological dependence.
  • Examples include anabolic steroids, hydrocodone,
    and codeine.

38
Schedule IV drugs
  • Findings required
  • (A) The drug or other substance has a low
    potential for abuse relative to the drugs or
    other substances in schedule III.
  • (B) The drug or other substance has a currently
    accepted medical use in treatment in the United
    States.
  • (C) Abuse of the drug or other substance may lead
    to limited physical dependence or psychological
    dependence relative to the drugs or other
    substances in schedule III.
  • Examples include benzodiazepines and barbituates.

39
Schedule V drugs
  • Findings required
  • (A) The drug or other substance has a low
    potential for abuse relative to the drugs or
    other substances in schedule IV.
  • (B) The drug or other substance has a currently
    accepted medical use in treatment in the United
    States.
  • (C) Abuse of the drug or other substance may lead
    to limited physical dependence or psychological
    dependence relative to the drugs or other
    substances in schedule IV.
  • Examples include cough syrups containing a small
    amount of codeine, or anti-diarrheals containing
    small amounts of diphenoxylate.
Write a Comment
User Comments (0)
About PowerShow.com